A5057869513- Neutropenia and Cancer Infections
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Streptococcal Infections and Treatments
- Bacterial Identification and Susceptibility Testing
- Childhood Cancer Survivors' Quality of Life
- SARS-CoV-2 detection and testing
- Acute Lymphoblastic Leukemia research
Hospital Base Guillermo Almenara Irigoyen
2022-2024
The addition of Biofire® FilmArray® Blood Culture Identification panel 2 (BCID2) to the antimicrobial stewardship program (ASP) could improve outcomes in bloodstream infections (BSI) patients with febrile neutropenia (FN). A pre- and post-quasi-experimental single-center study was conducted at a reference hospital Peru. Three groups were considered: BSI before ASP intervention (control group), after (group 1), plus BCID2 PCR Panel implementation 2). Overall, 93 identified (32 control, 30...
isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in seven patients with a diagnosis leukemia and confirmation disease (COVID-19) admitted to the Hematology Depart-
Background: Acute lymphoblastic leukemia (ALL) is the most common neoplasm in pediatric and adolescent populations. Overall survival has improved recent decades. This study aimed to assess overall of patients with ALL a Latin American hospital. Materials Methods: A longitudinal retrospective analytical was conducted on 31 less than 16 years age diagnosed at hematology department Peruvian hospital during period 2015-2016. 5 determined using Kaplan-Meier curve parametric log-rank tests, Cox...